« Back to Record
Loi, S., Estrada, M. V., Sanchez, V., Sanders, M. M., Cook, R. R., Pilkinton, M. A. L. M., Mallal, S. A., Wang, K., Miller, V. A., Stephens, P. J., Yelensky, R., Dushyanthen, S., Doimi, F. F., Gomez, H., Ryzhov, S. S., Darcy, P. K., Arteaga, C. L., Balko, J. M., Beavis, P. P., Salgado, R., Denkert, C., Savas, P., Combs, S., Rimm, D. D., & Giltnane, J. J. (2016). RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors. Clinical cancer research, 22(6), 1499-1509. doi:10.1158/1078-0432.CCR-15-1125
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231571



